2026 /4 /17
Lelune Clinic Implements RevoluX to Enhance Pediatric Care
Lelune Clinic, one of the first in Taiwan to adopt RevoluX, has been actively advancing pediatric growth medicine in recent years. Following its Taipei location, the clinic has recently established a new branch in Banqiao and continues to introduce low-dose RevoluX systems, providing a safe and convenient environment for pediatric bone age assessment.
2026 / 1 /30
NanoRay’s Auger Molecular Therapy Wins 2025 National Innovation Award
NanoRay Biotech’s innovative cancer precision therapy, Auger Molecular Therapy (AMT), has been honored with the 2025 National Innovation Award, showcasing the company’s R&D excellence in integrating radiation medicine with precision treatment.
2025 / 4 /24
NanoRay Recently Featured in Los Angeles Times for Revolutionary X-Ray
NanoRay was recently interviewed by the internationally renowned media outlet, Los Angeles Times, which provided an in-depth report on our forward-looking research and breakthrough applications in X-ray technology, highly recognizing NanoRay’s industry-leading and diverse innovations.
2023 / 11 /20
NanoRay Biotech’s Novel Cancer Therapy Approved for Phase I Clinical Trial
Nanoray Biotech recently announced that its new cancer therapy, Auger Molecular Therapy, has successfully received approval from Taiwan’s TFDA under IND review. The Phase 1 clinical trial will be conducted at Taipei Medical University, opening a new avenue for cancer treatment.
2023 / 11 /10
NanoRay Partners with Yuanpei University to Advance Innovative X-ray Technology
NanoRay Biotech Partners with Yuanpei University
On November 7, NanoRay Biotech and Yuanpei University of Medical Technology signed an MOU to collaborate on student training, internships, and X-ray technology research, aiming to drive innovation in medical and industrial X-ray applications.
2023 / 9 /28
NanoRay RevoluX Hand X-ray Shines at Thailand Medical Fair
NanoRay Biotech’s RevoluX hand X-ray system, a world-first innovation, has attracted significant attention in the international medical market. While actively promoting the product across Taiwan, NanoRay is expanding globally and was invited to participate in two major medical exhibitions in Thailand in September, drawing strong interest from potential buyers and distributors.
Looking ahead, NanoRay will continue participating in key global medical events, including the North American Radiology Annual Meeting (RSNA) and the Taiwan Medical Technology Expo in November, creating further opportunities for partnerships and collaboration.
2023 / 9 /11
Nanoray Biotech Co., publishes research and development results, international Symposium of Auger Electron attracts attention.
NanoRay Biotech is invited to present its current progress of Auger Molecular Therapy on Sep. 7, in 10th International Symposium on the Physical, Molecular, Cellular and Medical Aspects of Auger Electron Processes.
2023 / 8 /17
NanoRay Collaborates with Le lune Clinic for Pediatric Health and Growth Seminar
On August 27, NanoRay Biotech and Le lune Clinic hosted a seminar at ILLUME TAIPEI Hotel on “The Two Key Factors for Height Growth”, featuring Dr. Chuan-Hung Kao, pediatric genetic endocrinologist. The seminar shared key insights on children’s height development and the importance of early planning.
NanoRay Biotech aims to make bone age assessment more accessible across Taiwan, supporting children’s healthy and happy growth.
Register here: https://reurl.cc/r54y0N
2023 / 7 /12
NanoRay RevoluX Hand X-ray System – Supporting Children’s Growth with Care
The RevoluX hand X-ray system captures a child’s left hand in a single low-dose scan to assess bone age and growth status. NanoRay Biotech aims to make bone age checks more accessible, supporting children’s healthy and happy development.
2022 / 12 /5
NanoRay Honored with the National Innovation Award
NanoRay Biotech’s RevoluX, the world’s first desktop hand X-ray imaging system of its kind, received the 19th National Innovation Award – Enterprise Innovation Award (Medical Device Category), in addition to the 2021 iF Design Award and 2022 Taiwan Excellence Award, demonstrating strong recognition of its innovation in medical technology.
2022 / 11 /30
NanoRay Gains International Attention at the RSNA Annual Meeting
Following its successful debut at the Taiwan Expo held at Twin Oaks in Washington, D.C. in October, NanoRay Biotech further took the stage on November 27 at the internationally renowned Radiological Society of North America (RSNA) Annual Meeting in Chicago. The company’s innovative technologies attracted strong interest from leading global medical technology companies, leaving a lasting impression of Taiwan’s advancements in biotechnology and medical innovation.
2022 / 11 /16
Revolux hand diagnostic radiology imaging system will be launched at the ``Taiwan Healthcare Expo 2022``.
Revolux Hand Diagnostic Radiology Imaging System has been approved by the US FDA and will receive TFDA in December 2022, and will be launched at the “Taiwan Healthcare Expo 2022” booth M1132 from December 1st to December 4th.
2022 / 10 /31
Nanoray X-ray Non-Destructive Testing devices improve industry Quality Ccontrol
Nanoray has many years of experience in X-ray technology research and development, which is used in various industries, provides X-ray inspection solutions that meet the needs of industrial intelligent manufacturing, and also promotes AXI technology. Welcome distribution agents to discuss cooperation opportunities.
2022 / 10 /13
Revolux received great praise at the ``Taiwan Expo 2022`` in Washington, USA
Nanoray and INCX develop the Revolux hand diagnostic radiology imaging system – lower dose and safer. Revolux can provide applications such as bone age in children, bone density and rheumatoid arthritis.
2022 / 9 /25
“Congratulations to NanoRay Biotech for IND approval by US FDA for AMT clinical trial”
BIODURO-SUNDIA, a partner of NanoRay Biotech, posted congratulations for IND approval of NanoRay Biotech’s Auger Molecular Therapy (AMT) by US FDA for phase 1 clinical trial.
2022 / 9 /15
Auger Molecular Therapy (AMT) is approved by US FDA for first-in-human trial
NanoRay Biotech announced that AMT, an innovative cancer therapy modality has been approved by US FDA for phase 1 clinical trial. AMT is a combination therapy that includes a heavy-atom drug and the local irradiation with characteristic X-Ray beams, which lead to anti-cancer effect via induction of “Auger effect” in cancer DNA. AMT has been developed since 2016, verified for its efficacy and safety by pharmacodynamic, pharmacokinetic, and toxicology studies in pre-clinical models, and received IND approval in Sep. 2022. The first-in-human trial will be launched in Taipei Medical University Hospital (Taiwan) in 2023.
2022 / 8 /24
Nanoray successfully demonstrated a variety of industrial X-ray machines at ``Automation 2022``.
Nanoray, a leading X-ray tube manufacturer, exhibited X-ray component counters and X-ray inspection equipment with multi-axis operation for electronic SMT factories at the Taipei International Automation Industry Exhibition at Nangang Exhibition Hall from August 24th to 27th. The inspection and X-ray machines used in different fields such as green energy materials, food safety and drug testing, academic research projects, etc. have been recognized by the industry.
2022 / 8 / 5
Development of X-ray Non-Destructive Testing for Lithium Battery Manufacturing Process
The article discusses the application of X-ray technology in the inspection of various battery products, such as detection of foreign matters in raw materials cell stacking accuracy detection, electrolyte leakage detection, etc. which can effectively improve the quality and safty of batteries.
2022 / 5 / 1
USFDA approval of Revolux
On May 1st 2022, it was announced that Revolux officially gained approval from USFDA. For future application, NanoRay Biotech Co. aims to provide a better healthcare service in the medical needs of children’s bone age diagnosis, bone density detection for both the elderly men and women, early diagnosis for rheumatoid arthritis, as well as hand bone reconstructive surgery.
2021 / 11 / 4
Children's Bone Age Diagnosis X-Ray System won the ``Taiwan Excellence Award``
Congratulations to Nanoraybiotech’s Child Bone Age Diagnostic X-ray System_ RevoluX, which won the 30th “Taiwan Excellence Award”.
2020 / 7 / 1
Formally stationed in BioHub of the National Biotechnology Research Park for cancer treatment research and development_AMT
Nanoraybiotech R&D team was selected by the National Biotechnology Research Park and entered the BioHub for cancer treatment research and development.
2020 / 5 / 26
NanoRay News-Art painting restoration, research and detecting
X-ray non-destructive detection is a detection method that does not directly touch the object. Researchers can usually use it to evaluate the integrity and physical properties of the object and find valuable details that the naked eye cannot detect without harming the paintings and artworks.
2020 / 3 / 2
Major breakthrough in industrial inspection_NDT
Nanoray is committed to the development of non-destructive industrial inspection technology and equipment products. Existing AOI and AXI equipment take excellent images…
2020 / 4 / 20
NanoRay News-Food foreign material detection
In recent years, with the vigorous development of social media and the rising consumer awareness, the control of foreign materials in food has become an issue…
2020 / 2 / 20
Nanoray officially enters the medical imaging diagnostics market_MIS
Nanoray cooperated with Shanghai Medical Company to develop the detection of children’s bone age, and successfully developed a small-sized desktop low-dose children’s bone age detector. X-ray modules have officially entered the medical imaging diagnostic market.
2019 / 5 / 14
Breakthrough in non-destructive detection (NDT) applications
Nanoray has made a great breakthrough in the application of non-destructive detection (NDT)…
2020 / 1 / 2
Positive response from US FDA, commercialization of our Auger cancer treatment has made significant progress._AMT
The PreIND application has received a positive response from the US FDA at the end of last year. The FDA affirms Nanoray’s original combination product consisting of low-dose….
2019 / 7 / 25
Nanoray develops innovative low-emission Transmission X-ray technology
Nanoray is mainly engaged in the research and development of innovative low-emission Transmission X-ray technology….